Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.05    -1.65 (-3.32%)
Bid:
48.05
Ask:
49.65
Spread: 1.60 (3.33%)
Market Cap: £191.29m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Scrip Dividend Reference Share Price

16 Apr 2026 14:59

RNS Number : 8131A
CLS Holdings PLC
16 April 2026
 
 

CLS Holdings plc

("CLS" or the "Company")

Scrip Dividend Reference Share Price - 2025 Final Dividend

On 13 March 2026 the Company announced its final results for the year ending 31 December 2025 and that it would be recommending a 2025 final dividend of 2.7 pence per ordinary share of 2.5 pence each (a "Share"), fully paid as a Property Income Distribution (the "2025 Final Dividend").

Conditional upon the requisite resolutions being approved by shareholders at the 2026 Annual General Meeting, an enhanced scrip dividend is being offered to shareholders in respect of the 2025 Final Divided, as an alternative to the receiving the 2025 Final Dividend in cash (the "Enhanced Scrip Dividend Alternative").

If the resolutions required to offer the Enhanced Scrip Dividend Alternative are approved by the requisite majority at the 2026 Annual General Meeting, Shareholders who elect to participate in the Enhanced Scrip Dividend Alternative would receive new Shares with a value calculated on the basis of a discount of 5% to the Scrip Reference Share Price of 48.2 pence per Share.

This Scrip Reference Share Price is calculated as the average of the middle market quotations of a Share, derived from the London Stock Exchange Daily Official List, for the five Business Days starting on the day the Shares are first quoted ex-dividend, being from 9 April 2025 to 15 April 2025 (inclusive).

The deadline for applications for the Enhanced Scrip Dividend Alternative in respect of the 2025 Final Dividend is 5 pm (London time) on 30 April 2026. More details of the Enhanced Scrip Dividend Alternative, including details on how to elect to receive the Enhanced Scrip Dividend Alternative, are available on the Company's website at www.clsholdings.com.

 

-ends-

For further information, please contact:

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

David Fuller, Company Secretary

+44 (0)20 7582 7766

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVAKABPNBKDOQD
Date   Source Headline
13th Mar 20187:00 amRNSAcquisition
12th Mar 20185:43 pmRNSDirector/PDMR Shareholding
8th Mar 20185:42 pmRNSDirector/PDMR Shareholding
8th Mar 20185:35 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSFinal Results
9th Feb 20185:19 pmRNSDirector/PDMR Shareholding
7th Feb 201812:02 pmRNSPrice Monitoring Extension
19th Jan 20187:00 amRNSChange of Joint Corporate Broker
9th Jan 20185:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20187:00 amRNSDisposals
21st Dec 201712:07 pmRNSSecond Price Monitoring Extn
21st Dec 201712:02 pmRNSPrice Monitoring Extension
7th Dec 20175:10 pmRNSDirector/PDMR Shareholding
7th Dec 201712:15 pmRNSDirectorate Change
9th Nov 20177:00 amRNSAcquisition
8th Nov 20174:24 pmRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSDisposal
25th Oct 20171:43 pmRNSEarly redemption of outstanding amortising bonds
9th Oct 20175:25 pmRNSDirector/PDMR Shareholding
4th Oct 20177:00 amRNSRenewal of Government Leases
22nd Sep 20179:47 amRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSDisposal
11th Sep 201711:52 amRNSDirector/PDMR Shareholding
22nd Aug 20177:00 amRNSCompletion of German portfolio acquisition
16th Aug 201711:28 amRNSDividend Timetable
16th Aug 20177:00 amRNSHalf-year Report
9th Aug 201712:31 pmRNSDirector/PDMR Shareholding
22nd Jun 20174:35 pmRNSPrice Monitoring Extension
14th Jun 20177:00 amRNSAcquisition
30th May 20177:00 amRNSAcquisition
17th May 20174:35 pmRNSPrice Monitoring Extension
16th May 20173:40 pmRNSDirectorate Change
8th May 20179:24 amRNSCompletion of Share Subdivision & TVR
4th May 201711:21 amRNSCompletion of Sale of Vauxhall Square
28th Apr 20172:52 pmRNSDirector/PDMR Shareholding
26th Apr 20174:02 pmRNSShare Subdivision Timetable
26th Apr 20173:26 pmRNSDirector/PDMR Shareholding
26th Apr 20173:21 pmRNSResult of AGM
5th Apr 201712:14 pmRNSSale of Vauxhall Square
24th Mar 20174:39 pmRNSPublication of Annual Report and Notice of AGM
23rd Mar 20177:00 amRNSDisposal
21st Mar 20177:00 amRNSAcquisition
15th Mar 20174:07 pmRNSDividend Timetable
8th Mar 20177:00 amRNSFinal Results
7th Mar 20173:57 pmRNSDirectorate Changes
8th Feb 20177:00 amRNSIntroduction of Dividend
18th Jan 20174:22 pmRNSTrading Statement
11th Jan 20177:00 amRNSAcquisitions
16th Dec 20164:40 pmRNSSecond Price Monitoring Extn
16th Dec 20164:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.